ArticleFrontiers in oncology2020

Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer:

Guang-Yi Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.